Category: Diabetes treatment

Approved by the FDA in 2006, Januvia (sitagliptin) was the first drug in a new class of diabetes treatments known as DPP-4 inhibitors. Understanding **what is the classification of Januvia** is key to grasping how this oral medication effectively manages blood sugar levels in adults with type 2 diabetes.

Danish pharmaceutical company Novo Nordisk, founded by Nobel laureate August Krogh and his wife Marie, a doctor with diabetes, is the creator of Ozempic. The innovative drug was the result of years of research into glucagon-like peptide-1 (GLP-1) agonists and helped redefine the treatment landscape for type 2 diabetes and obesity.